Posts Tagged ‘by Amanda Conschafter – blog editor’

Governors Take on Abuse and Access in Opioid Compact

State governors are ready to take action on the opioid abuse epidemic. The National Governors Association released “A Compact to Fight Opioid Addiction” on July

Read More

Advocates Urge Congress to Finalize 21st Century Cures

Congress returns in September from a seven-week recess—and ready, many patients and advocates hope, to push the 21st Century Cures Act over the finish line.

Read More

World Hepatitis Day Spotlights Disease Elimination & Access Efforts

July 28 marks World Hepatitis Day, part of the World Health Organization’s effort to eliminate hepatitis B and C by 2030. Each year, 10 million

Read More

New Industry Principles Encourage Informed Prescribing

Access to comprehensive information about a medication can keep physicians informed and yield better health care decisions, argues a new set of principles from the

Read More

What Cancer Drugs Might Mean for Alzheimer’s and Parkinson’s Patients

Patients with Alzheimer’s or Parkinson’s disease may have a new source of hope: cancer drugs. A study in the Journal of Parkinson’s Disease reported promising

Read More

FDA Hearings Underscore Need for Clear Policy on Biosimilars

July 12 and 13 hearings of the FDA’s Arthritis Advisory Committee cleared the way for two new biosimilars, adalimumab and etanercerpt. The committee unanimously supported

Read More

Senators Urge Action on National Pain Strategy

A bipartisan group of U.S. senators has a question for HHS Secretary Sylvia Burwell: Any progress on the National Pain Strategy? In a letter to

Read More

AfPA Releases Video on Barriers to Asthma Care

Breathing complications aren’t the only challenge faced by the 26 million Americans with asthma, explains a new video from the Alliance for Patient Access. Health

Read More

CMS Models Shake Up Cancer Care

The Centers for Medicare and Medicaid Services’ Oncology Care Model is off and running. As announced during The White House’s cancer summit at Howard University,

Read More

Global Poster Presentations Convey Need for Distinct Biosimilar Names

Patient advocates have teamed up to take an important message to European physicians and policymakers: distinct names for biosimilar medications are essential. The Global Alliance

Read More
Back to Top